Secondaries Announced 6.27.17

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period. Spot secondaries or block trades due to the very short duration of announcement to trading, may take longer to “work”, and should be judged accordingly. (the key is the pricing for spots and or blocks…even more so than scheduled secondaries)
Company: Global Medical REIT Inc.
Symbol: GMRE
Price: Last trade $9.81
Trade Date: 6/28
Re-offer Range: $9.00-$9.00
Shares: 3.5 million
Underwriter(s) : Janney Montgomery Scott, Wunderlich, BMO Capital Markets
Rating = Neutral
Company: Minerva Neurosciences, Inc.
Symbol: NERV
Price: Last Trade $8.60
Trade Date: 6/29
Shares: 5 million
Underwriter(s) : Citigroup, Jefferies
Rating = BUY